Skip to Content
Merck
  • Consequences of misdiagnosis and mismanagement of Takotsubo cardiomyopathy.

Consequences of misdiagnosis and mismanagement of Takotsubo cardiomyopathy.

Acute cardiac care (2012-12-12)
Chirayu Vyas, Sanjay Shah, Sameer Pancholy, Tejas Patel, Isam Moussa
ABSTRACT

We report a patient who presented with takotsubo cardiomyopathy but was misdiagnosed as an anterior wall ST elevation myocardial infarction (AWMI). We illustrate how misdiagnosis led to mismanagement by initiating intravenous inotropic agents that led to further hemodynamic compromise. Subsequent withdrawal of the inotropic agents and simultaneous administration of oral metoprolol therapy led to hemodynamic and clinical improvement re-affirming the diagnosis of takotsubo cardiomyopathy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-Metoprolol (+)-tartrate salt, ≥98% (titration), powder
Metoprolol tartrate, European Pharmacopoeia (EP) Reference Standard
Supelco
Metoprolol Tartrate, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Metoprolol tartrate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®